Who is sponsoring NCT04442152?

NCT04442152 is sponsored by Promundo, United States.

What drugs are being tested in NCT04442152?

Interventions in NCT04442152: MenCare+/Bandebereho fathers'/couples' group education.

What condition does NCT04442152 study?

NCT04442152 studies Gender Relations, Partner Communication, Division of Carework, Couple Conflict, Stress.

Is NCT04442152 still recruiting?

NCT04442152 is currently completed. Last updated 15 March 2022.

Last reviewed 2022-03-15 · How we verify

NCT04442152

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants

Completed NA Last updated 15 March 2022

What this trial tests

NA trial testing MenCare+/Bandebereho fathers'/couples' group education in Gender Relations in 998 participants. Completed in 4 September 2020.

Timeline

13 August 2020

Primary endpoint
4 September 2020

4 September 2020

Quick facts

Lead sponsor	Promundo, United States
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	998
Start date	13 August 2020
Primary completion	4 September 2020
Estimated completion	4 September 2020
Sites	1 location across Rwanda

Drugs / interventions tested

MenCare+/Bandebereho fathers'/couples' group education

Conditions studied

Gender Relations — all drugs for Gender Relations →
Partner Communication — all drugs for Partner Communication →
Division of Carework — all drugs for Division of Carework →
Couple Conflict — all drugs for Couple Conflict →

Sponsor

Promundo, United States

Who can join

Adults 26 to 40, any sex, with Gender Relations or Partner Communication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This proposed study will assess how COVID-19 and the associated 'stay at home' orders are affecting low-income Rwandan couples' relationships and family dynamics. The study builds on an existing randomized controlled trial of the Bandebereho fathers/couples intervention (NCT02694627), which will allow us to assess not only the current conditions in households, but also whether or how the significant impacts of the intervention are sustained under extreme stress.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of MenCare+/Bandebereho fathers'/couples' group education

Trials testing the same drug.

NCT04861870 — Bandebereho 6 Year Follow up RCT in Rwanda · NA · completed

Other Promundo, United States trials

Trials by the same sponsor.

NCT04861870 — Bandebereho 6 Year Follow up RCT in Rwanda · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04442152 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Promundo, United States
Last refreshed: 15 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04442152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing